BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Pharm Country

  Wills Eye Hospital Earns National Recognition for Excellence

  America’s Physicians Voted Hospital’s Ophthalmology Training Program #1 and in Top 2 overall in 2018-19 U.S. News & World Report Hospital Rankings

  August 14, 2018

   · 

  3 min read
• Healthcare system needs to catch up to the requirements of the Google Generation

  New CMA report addresses growing healthcare generation gap driven by tech-savvy Canadians 18-34

  August 14, 2018

   · 

  3 min read
• BiondVax Receives Second €6M Tranche Disbursement From the European Investment Bank (EIB)

  BiondVax Pharmaceuticals Ltd. announced today the receipt of a €6 million disbursement from the European Investment Bank (EIB).

  August 14, 2018

   · 

  4 min read
• Policy

  MAXIMUS Awarded North Carolina Department of Health and Human Services Contract for Medicaid Managed Care Enrollment Broker Services

  MAXIMUS announced today that it has signed a new contract with the North Carolina Department of Health and Human Services (DHHS) to provide Medicaid managed care enrollment broker services.

  August 14, 2018

   · 

  3 min read
• Business

  Sesen Bio Reports Second Quarter 2018 Financial Results and Pipeline Updates

  FDA Grants Fast Track Designation for Vicinium in NMIBC

  August 14, 2018

   · 

  10 min read
• Business

  Neuronetics Reports Second Quarter 2018 Financial and Operating Results

  Neuronetics, Inc. announced its financial and operating results for the second quarter ended June 30, 2018.

  August 14, 2018

   · 

  12 min read
• Business

  Sharps Compliance Reports Fiscal 2018 Fourth Quarter and Year End Results

  Fourth quarter 2018 revenue was $9.9 million with gross margin of 30% and net loss per share of $0.01

  August 14, 2018

   · 

  20 min read
• Business

  Biostage Reports 2018 Second Quarter Financial Results

  Company making steady progress on mid-term goals

  August 14, 2018

   · 

  21 min read
• Business

  CASI Pharmaceuticals Announces Second Quarter And First Half 2018 Financial And Business Results

  China FDA (CFDA) import drug registration priority review of EVOMELA® in progress and preparations continue for its commercial launch in China

  August 14, 2018

   · 

  11 min read
• Business

  Cronos Group Inc. Announces Second Quarter 2018 Results

  Increased Sales 428% Year-over-Year

  August 14, 2018

   · 

  32 min read